APO Research
Talk to an analyst

APO RESEARCH · REPORT

Gout Drugs

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Gout Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

20 December 2025197 pages

Choose your research edition.

Industry ResearchGout Drugs Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Gout Drugs Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Gout Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Gout Drugs Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Gout Drugs Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Gout Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Gout Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Gout Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Gout Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Gout Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Gout Drugs include Accord, Apotex, Ipca, KPC, Northstar, PIDI, Synpac-Kingdom, Mylan and Sun Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Gout Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Gout Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Gout Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Gout Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Gout Drugs Segment by Company

Accord

Apotex

Ipca

KPC

Northstar

PIDI

Synpac-Kingdom

Mylan

Sun Pharma

Yunnan Phytopharmaceutical

Gout Drugs Segment by Type

Benzbromo Malone

Allopurinol

Febuxostat

Colchicine

Other

Gout Drugs Segment by Application

Acute gout

Chronic gout

Gout Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gout Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Gout Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gout Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Gout Drugs market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Gout Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Gout Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Gout Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Gout Drugs Industry Trends Table 2. Gout Drugs Industry Drivers Table 3. Gout Drugs Industry Opportunities and Challenges Table 4. Gout Drugs Industry Restraints Table 5. Global Gout Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Gout Drugs Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Gout Drugs Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Gout Drugs Sales Market Share by Manufacturers Table 9. Global Gout Drugs Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Gout Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Gout Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Gout Drugs Manufacturers, Product Type & Application Table 13. Global Gout Drugs Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Gout Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Benzbromo Malone Table 17. Major Manufacturers of Allopurinol Table 18. Major Manufacturers of Febuxostat Table 19. Major Manufacturers of Colchicine Table 20. Major Manufacturers of Other Table 21. Global Gout Drugs Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 22. Global Gout Drugs Sales by Type (2021-2026) & (K Units) Table 23. Global Gout Drugs Sales by Type (2027-2032) & (K Units) Table 24. Global Gout Drugs Sales Market Share by Type (2021-2026) Table 25. Global Gout Drugs Sales Market Share by Type (2027-2032) Table 26. Global Gout Drugs Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 27. Global Gout Drugs Revenue by Type (2021-2026) & (K Units) Table 28. Global Gout Drugs Revenue by Type (2027-2032) & (K Units) Table 29. Global Gout Drugs Revenue Market Share by Type (2021-2026) Table 30. Global Gout Drugs Revenue Market Share by Type (2027-2032) Table 31. Major Manufacturers of Acute gout Table 32. Major Manufacturers of Chronic gout Table 33. Global Gout Drugs Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Gout Drugs Sales by Application (2021-2026) & (K Units) Table 35. Global Gout Drugs Sales by Application (2027-2032) & (K Units) Table 36. Global Gout Drugs Sales Market Share by Application (2021-2026) Table 37. Global Gout Drugs Sales Market Share by Application (2027-2032) Table 38. Global Gout Drugs Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 39. Global Gout Drugs Revenue by Application (2021-2026) & (K Units) Table 40. Global Gout Drugs Revenue by Application (2027-2032) & (K Units) Table 41. Global Gout Drugs Revenue Market Share by Application (2021-2026) Table 42. Global Gout Drugs Revenue Market Share by Application (2027-2032) Table 43. Global Gout Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Gout Drugs Sales by Region (2021-2026) & (K Units) Table 45. Global Gout Drugs Sales Market Share by Region (2021-2026) Table 46. Global Gout Drugs Sales Forecasted by Region (2027-2032) & (K Units) Table 47. Global Gout Drugs Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Gout Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. North America Gout Drugs Sales by Country (2021-2026) & (K Units) Table 50. North America Gout Drugs Sales by Country (2027-2032) & (K Units) Table 51. Europe Gout Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Europe Gout Drugs Sales by Country (2021-2026) & (K Units) Table 53. Europe Gout Drugs Sales by Country (2027-2032) & (K Units) Table 54. Asia Pacific Gout Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Asia Pacific Gout Drugs Sales by Country (2021-2026) & (K Units) Table 56. Asia Pacific Gout Drugs Sales by Country (2027-2032) & (K Units) Table 57. South America, Middle East and Africa Gout Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. South America, Middle East and Africa Gout Drugs Sales by Country (2021-2026) & (K Units) Table 59. South America, Middle East and Africa Gout Drugs Sales by Country (2027-2032) & (K Units) Table 60. Global Gout Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Gout Drugs Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Gout Drugs Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Gout Drugs Revenue Market Share by Region (2021-2026) Table 64. Global Gout Drugs Revenue Market Share by Region (2027-2032) Table 65. Accord Company Information Table 66. Accord Business Overview Table 67. Accord Gout Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Accord Gout Drugs Product Portfolio Table 69. Accord Recent Development Table 70. Apotex Company Information Table 71. Apotex Business Overview Table 72. Apotex Gout Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Apotex Gout Drugs Product Portfolio Table 74. Apotex Recent Development Table 75. Ipca Company Information Table 76. Ipca Business Overview Table 77. Ipca Gout Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Ipca Gout Drugs Product Portfolio Table 79. Ipca Recent Development Table 80. KPC Company Information Table 81. KPC Business Overview Table 82. KPC Gout Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. KPC Gout Drugs Product Portfolio Table 84. KPC Recent Development Table 85. Northstar Company Information Table 86. Northstar Business Overview Table 87. Northstar Gout Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Northstar Gout Drugs Product Portfolio Table 89. Northstar Recent Development Table 90. PIDI Company Information Table 91. PIDI Business Overview Table 92. PIDI Gout Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. PIDI Gout Drugs Product Portfolio Table 94. PIDI Recent Development Table 95. Synpac-Kingdom Company Information Table 96. Synpac-Kingdom Business Overview Table 97. Synpac-Kingdom Gout Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Synpac-Kingdom Gout Drugs Product Portfolio Table 99. Synpac-Kingdom Recent Development Table 100. Mylan Company Information Table 101. Mylan Business Overview Table 102. Mylan Gout Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. Mylan Gout Drugs Product Portfolio Table 104. Mylan Recent Development Table 105. Sun Pharma Company Information Table 106. Sun Pharma Business Overview Table 107. Sun Pharma Gout Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. Sun Pharma Gout Drugs Product Portfolio Table 109. Sun Pharma Recent Development Table 110. Yunnan Phytopharmaceutical Company Information Table 111. Yunnan Phytopharmaceutical Business Overview Table 112. Yunnan Phytopharmaceutical Gout Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 113. Yunnan Phytopharmaceutical Gout Drugs Product Portfolio Table 114. Yunnan Phytopharmaceutical Recent Development Table 115. Key Raw Materials Table 116. Raw Materials Key Suppliers Table 117. Gout Drugs Distributors List Table 118. Gout Drugs Customers List Table 119. Research Programs/Design for This Report Table 120. Authors List of This Report Table 121. Secondary Sources Table 122. Primary Sources List of Figures Figure 1. Gout Drugs Product Image Figure 2. Global Gout Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Gout Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Gout Drugs Sales (2021-2032) & (K Units) Figure 5. Global Gout Drugs Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Gout Drugs Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Benzbromo Malone Image Figure 9. Allopurinol Image Figure 10. Febuxostat Image Figure 11. Colchicine Image Figure 12. Other Image Figure 13. Global Gout Drugs Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Gout Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 15. Global Gout Drugs Sales Market Share by Type (2021-2032) Figure 16. Global Gout Drugs Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 17. Global Gout Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Gout Drugs Revenue Market Share by Type (2021-2032) Figure 19. Acute gout Image Figure 20. Chronic gout Image Figure 21. Global Gout Drugs Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Gout Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Gout Drugs Sales Market Share by Application (2021-2032) Figure 24. Global Gout Drugs Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 25. Global Gout Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Gout Drugs Revenue Market Share by Application (2021-2032) Figure 27. North America Gout Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 28. North America Gout Drugs Sales Market Share by Country (2021-2032) Figure 29. U.S. Gout Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Canada Gout Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Mexico Gout Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Gout Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe Gout Drugs Sales Market Share by Country (2021-2032) Figure 34. Germany Gout Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 35. France Gout Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 36. U.K. Gout Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Italy Gout Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Netherlands Gout Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Gout Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific Gout Drugs Sales Market Share by Country (2021-2032) Figure 41. China Gout Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Japan Gout Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 43. South Korea Gout Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Southeast Asia Gout Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 45. India Gout Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 46. Australia Gout Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Gout Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa Gout Drugs Sales Market Share by Country (2021-2032) Figure 49. Brazil Gout Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South Africa Gout Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Saudi Arabia Gout Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Turkey Gout Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Argentina Gout Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 54. UAE Gout Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Egypt Gout Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Chile Gout Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Global Gout Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Gout Drugs Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Gout Drugs Revenue (2021-2032) & (US$ Million) Figure 60. North America Gout Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Gout Drugs Revenue (2021-2032) & (US$ Million) Figure 62. Europe Gout Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Gout Drugs Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Gout Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Gout Drugs Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Gout Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Gout Drugs Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Gout Drugs Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Benzbromo Malone
  • Allopurinol
  • Febuxostat
  • Colchicine
  • Other
Applications
  • Acute gout
  • Chronic gout
Companies covered
  • Accord
  • Apotex
  • Ipca
  • KPC
  • Northstar
  • PIDI
  • Synpac-Kingdom
  • Mylan
  • Sun Pharma
  • Yunnan Phytopharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Gout Drugs Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Gout Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Gout Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Gout Drugs Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Gout Drugs Market Dynamics
  1. 2.1 Gout Drugs Industry Trends
  2. 2.2 Gout Drugs Industry Drivers
  3. 2.3 Gout Drugs Industry Opportunities and Challenges
  4. 2.4 Gout Drugs Industry Restraints
3 Gout Drugs Market by Manufacturers
  1. 3.1 Global Gout Drugs Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Gout Drugs Sales by Manufacturers (2021-2026)
  3. 3.3 Global Gout Drugs Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Gout Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Gout Drugs Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Gout Drugs Manufacturers, Product Type & Application
  7. 3.7 Global Gout Drugs Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Gout Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Gout Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Gout Drugs Tier 1, Tier 2, and Tier 3
4 Gout Drugs Market by Type
  1. 4.1 Gout Drugs Type Introduction
  2. 4.1.1 Benzbromo Malone
  3. 4.1.2 Allopurinol
  4. 4.1.3 Febuxostat
  5. 4.1.4 Colchicine
  6. 4.1.5 Other
  7. 4.2 Global Gout Drugs Sales by Type
  8. 4.2.1 Global Gout Drugs Sales by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Gout Drugs Sales by Type (2021-2032)
  10. 4.2.3 Global Gout Drugs Sales Market Share by Type (2021-2032)
  11. 4.3 Global Gout Drugs Revenue by Type
  12. 4.3.1 Global Gout Drugs Revenue by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Gout Drugs Revenue by Type (2021-2032)
  14. 4.3.3 Global Gout Drugs Revenue Market Share by Type (2021-2032)
5 Gout Drugs Market by Application
  1. 5.1 Gout Drugs Application Introduction
  2. 5.1.1 Acute gout
  3. 5.1.2 Chronic gout
  4. 5.2 Global Gout Drugs Sales by Application
  5. 5.2.1 Global Gout Drugs Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Gout Drugs Sales by Application (2021-2032)
  7. 5.2.3 Global Gout Drugs Sales Market Share by Application (2021-2032)
  8. 5.3 Global Gout Drugs Revenue by Application
  9. 5.3.1 Global Gout Drugs Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Gout Drugs Revenue by Application (2021-2032)
  11. 5.3.3 Global Gout Drugs Revenue Market Share by Application (2021-2032)
6 Global Gout Drugs Sales by Region
  1. 6.1 Global Gout Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Gout Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Gout Drugs Sales by Region (2021-2026)
  4. 6.2.2 Global Gout Drugs Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Gout Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Gout Drugs Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Gout Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Gout Drugs Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Gout Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Gout Drugs Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Gout Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Gout Drugs Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Gout Drugs Revenue by Region
  1. 7.1 Global Gout Drugs Revenue by Region
  2. 7.1.1 Global Gout Drugs Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Gout Drugs Revenue by Region (2021-2026)
  4. 7.1.3 Global Gout Drugs Revenue by Region (2027-2032)
  5. 7.1.4 Global Gout Drugs Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Gout Drugs Revenue (2021-2032)
  8. 7.2.2 North America Gout Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Gout Drugs Revenue (2021-2032)
  11. 7.3.2 Europe Gout Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Gout Drugs Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Gout Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Gout Drugs Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Gout Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Accord
  2. 8.1.1 Accord Company Information
  3. 8.1.2 Accord Business Overview
  4. 8.1.3 Accord Gout Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Accord Gout Drugs Product Portfolio
  6. 8.1.5 Accord Recent Developments
  7. 8.2 Apotex
  8. 8.2.1 Apotex Company Information
  9. 8.2.2 Apotex Business Overview
  10. 8.2.3 Apotex Gout Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Apotex Gout Drugs Product Portfolio
  12. 8.2.5 Apotex Recent Developments
  13. 8.3 Ipca
  14. 8.3.1 Ipca Company Information
  15. 8.3.2 Ipca Business Overview
  16. 8.3.3 Ipca Gout Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Ipca Gout Drugs Product Portfolio
  18. 8.3.5 Ipca Recent Developments
  19. 8.4 KPC
  20. 8.4.1 KPC Company Information
  21. 8.4.2 KPC Business Overview
  22. 8.4.3 KPC Gout Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 KPC Gout Drugs Product Portfolio
  24. 8.4.5 KPC Recent Developments
  25. 8.5 Northstar
  26. 8.5.1 Northstar Company Information
  27. 8.5.2 Northstar Business Overview
  28. 8.5.3 Northstar Gout Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Northstar Gout Drugs Product Portfolio
  30. 8.5.5 Northstar Recent Developments
  31. 8.6 PIDI
  32. 8.6.1 PIDI Company Information
  33. 8.6.2 PIDI Business Overview
  34. 8.6.3 PIDI Gout Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 PIDI Gout Drugs Product Portfolio
  36. 8.6.5 PIDI Recent Developments
  37. 8.7 Synpac-Kingdom
  38. 8.7.1 Synpac-Kingdom Company Information
  39. 8.7.2 Synpac-Kingdom Business Overview
  40. 8.7.3 Synpac-Kingdom Gout Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Synpac-Kingdom Gout Drugs Product Portfolio
  42. 8.7.5 Synpac-Kingdom Recent Developments
  43. 8.8 Mylan
  44. 8.8.1 Mylan Company Information
  45. 8.8.2 Mylan Business Overview
  46. 8.8.3 Mylan Gout Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Mylan Gout Drugs Product Portfolio
  48. 8.8.5 Mylan Recent Developments
  49. 8.9 Sun Pharma
  50. 8.9.1 Sun Pharma Company Information
  51. 8.9.2 Sun Pharma Business Overview
  52. 8.9.3 Sun Pharma Gout Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Sun Pharma Gout Drugs Product Portfolio
  54. 8.9.5 Sun Pharma Recent Developments
  55. 8.10 Yunnan Phytopharmaceutical
  56. 8.10.1 Yunnan Phytopharmaceutical Company Information
  57. 8.10.2 Yunnan Phytopharmaceutical Business Overview
  58. 8.10.3 Yunnan Phytopharmaceutical Gout Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Yunnan Phytopharmaceutical Gout Drugs Product Portfolio
  60. 8.10.5 Yunnan Phytopharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Gout Drugs Value Chain Analysis
  2. 9.1.1 Gout Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Gout Drugs Production Mode & Process
  6. 9.2 Gout Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Gout Drugs Distributors
  9. 9.2.3 Gout Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst